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Edited by Richard MaraisAbstract Apoptosis-inducing factor (AIF) is a ubiquitous FAD-
binding ﬂavoprotein comprised of 613 amino acids and plays an
important role in caspase-independent apoptosis. During apopto-
tic induction, AIF is translocated from the mitochondrial inter-
membrane space to the nucleus, where it interacts with DNA
and activates a nuclear endonuclease. By performing a yeast
two-hybrid screen with mature AIF, we have isolated the eukary-
otic translation initiation factor 3 subunit p44 (eIF3g). Our dele-
tion mutant analysis revealed that the eIF3g N-terminus
interacts with the C-terminal region of AIF. The direct interac-
tion between AIF and eIF3g was conﬁrmed in a GST pull-down
assay and also veriﬁed by the results of co-immunoprecipitation
and confocal microscopy studies. Using an in vitro TNT coupled
transcription–translation system, we found that mature AIF
could inhibit newly-translated protein synthesis and this inhibi-
tion was signiﬁcantly blocked by eIF3g competitively. These re-
sults were also conﬁrmed in cells. In addition, mature AIF
overexpression speciﬁcally resulted in the activation of cas-
pase-7, thereby amplifying the inhibition of protein synthesis
including eIF3g cleavage. Our data suggest that eIF3g is one
of the cytosolic targets that interacts with mature AIF, and pro-
vide insight into the AIF’s cellular functions of the inhibition of
protein synthesis during apoptosis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Apoptosis plays a critical role in important biological pro-
cesses such as morphogenesis, tissue homeostasis, and immu-Abbreviations: AIF, apoptosis-inducing factor; eIF, eukaryotic trans-
lation initiation factor; MLS, mitochondrial localization sequence;
RRM, RNA recognition motif
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contribute to a number of diseases [1,2]. Cells undergoing
apoptosis usually exhibit a characteristic morphology, includ-
ing apoptotic body formation, fragmentation of the cellular
proteins, nuclear and cytoplasmic condensation, and chromo-
somal DNA cleavage. These characteristics of apoptosis com-
prise both caspase-dependent and caspase-independent
pathways. Caspases are major mediators involved in several
death pathways, such as extrinsic death receptor-mediated or
intrinsic mitochondria-mediated signaling. Caspase activation
aﬀects a number of substrates that have important biological
functions, leading to the loss of their functional roles.
Apoptosis-inducing factor (AIF) has been identiﬁed as an
apoptogenic mitochondrial intermembrane protein and has
been demonstrated to play roles as a caspase-independent
apoptotic factor [3–7]. Similar to cytochrome c (Cyt-c), AIF
is likely to be a phylogenetically ancient, bifunctional protein
that exhibits an oxidoreductase function [8–10]. The AIF pre-
cursor protein (613 amino acids) contains an N-terminal mito-
chondrial localization sequence (MLS) by which the protein is
guided to the mitochondrial intermembrane space (MIS). It is
synthesized in the cytoplasmic ribosomes and then imported
into the MIS, where the MLS is removed by the calcium-acti-
vated protease calpain [5,11]. The large C-terminal domain of
AIF shares signiﬁcant homology with oxidoreductases from
vertebrates to invertebrates, and it has mitochondrial NADH
oxidase activity [9]. During apoptotic induction, such as follow-
ing treatment with staurosporin or cisplatin, the mitochondria
release mature AIF and other soluble proteins of the intermem-
brane space such as Cyt-c. When cells are transfected with an
AIF deletion mutant lacking a MLS, AIF accumulates in the
extramitochondrial compartments, in particular the nuclei.
This results in chromatin condensation and cell death [12]. In
addition, some evidence suggests that sequence-independent
DNA binding of AIF is required for its apoptogenic functions
[13,14]. In cells treated with apoptotic stimuli, endogenous AIF
becomes co-localized with DNA at an early stage of nuclear
morphological change. Structure-based mutagenesis reveals
that DNA-binding defective mutants of AIF fail to induce
cell death, while retaining nuclear translocation characteristics.
One major diﬀerence between AIF-induced and Cyt-c/caspase/blished by Elsevier B.V. All rights reserved.
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chromatin condensation. AIF causes only a partial condensa-
tion without shrinkage, whereas CAD (caspase-activated
DNase) induces a more advanced condensation pattern [7]. An-
other diﬀerence involves the degree of chromatin degradation
induced by AIF and CAD. AIF induces (caspase-indepen-
dently) large-scale (50 kbp) DNA fragmentation [12,15],
whereas CAD triggers a more classical oligonucleosomal pat-
tern of DNA fragmentation, leading to the production of mul-
tiples of 200 bp. However, the exact mechanism by which AIF
induces chromatin condensation and DNA fragmentation has
yet to be elucidated. To date, AIF has been reported to interact
with heat shock protein 70 (HSP70), an anti-apoptotic protein
that binds to Apaf-1, forming the apoptosome [16–18], and
cyclophilin A (CypA) which binds with immunosuppressive
cyclosporin A (CyA) [19]. It has been shown that HSP70 inhib-
its the translocation of AIF to the nucleus and AIF-induced
chromatin condensation of puriﬁed nuclei, and that apoptosis
is ineﬃciently carried out in CypA-knockout cells or with
AIF mutants lacking the CypA-binding domain.
In order to explore possible interactions related to the
molecular function of AIF in the mitochondria, cytosol, and
nucleus, we performed a yeast two-hybrid screen using the mu-
tant AIFD1–101 (a mature AIF that translocates to the nu-
cleus) as the bait. One of the positive clones, which encoded
a subunit of eukaryotic translation initiation factor 3, eIF3g,
was analyzed in more depth. eIF3, which comprises the eIF
machinery, is a large translation initiation complex containing
at least 13 subunits [20,21]. eIF3 plays a central role in the
binding of the initiator methionyl-tRNA and mRNA with
the 40S ribosomal subunit to initiate translation [22]. In this
study, we demonstrate that mature AIF released from mito-
chondria interacts speciﬁcally with eIF3g in the eIF3 complex,
thereby blocking translation initiation. These data make it
clear that eIF3g, though its exact role in apoptosis is yet unde-
ﬁned, is one of the cytosolic factors that bind to the mature
form of AIF.2. Materials and methods
2.1. Cell culture and treatment
Jurkat or MCF-7 cells were cultured in RPMI 1640 (Sigma, St.
Louis, MO), and HeLa and HEK293 cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM; Gibco-BRL, Grand Island, NY)
supplemented with 10% heat-inactivated fetal bovine serum (FBS;
Gibco-BRL), 1% penicillin, streptomycin, and 2 mM glutamine in a
humidiﬁed 5% CO2 incubator.2.2. Antibodies
Antibodies used in this study are as follows: rabbit anti-AIF and anti-
GFP antibody (Santa Cruz Biotechnology, Santa Cruz, CA), mouse
anti-GST antibody (Molecular Probes, Eugene, OR), mouse anti-HA
and anti-a-tubulin antibody, TRITC- or HRP-conjugated secondary
antibody (Sigma), mouse anti-caspase-3 antibody (Calbiochem, San
Diego, CA), rabbit anti-caspase-6 and anti-caspase-7 antibody (Cell
Signaling Technology, Beverly, MA). Rabbit anti-eIF3g antibody was
kindly provided by Dr. Tang K. Tang (Institute of Biomedical Sciences,
Taiwan), and we also generated polyclonal anti-eIF3g antibody from
mouse via the injection of puriﬁed recombinant eIF3g protein.2.3. Plasmid construction
In order to analyze the interaction between AIF and eIF3g, using a
yeast two-hybrid system, the DNA fragments encoding AIF wt (amino
acids 1–613), -mat (D1–101), -N (1–153), -M1 (102–323), -M2 (102–439), -M3 (310–439), -C2 (373–613), -C1 (440–613), and -C3 (500–
613) were cloned into the pLexA vector (Clontech, Palo Alto, CA).
eIF3g wt (amino acids 1–320), -DR (D230–320), -C1 (230–320), -C2
(114–320), and -DN (D1–74) were cloned into the pB42AD vector.
For in vitro coupled transcription–translation analysis, the cDNAs
of AIF, eIF3g, eIF3i, eIF3j, GFP, and luciferase were cloned into
the pcDNA3 (or pcDNA3HA) vector (Invitrogen, Carlsbad, CA).
To generate recombinant glutathione-S-transferase (GST) fusion pro-
teins, DNA fragments were cloned into the pGEX-5X-1 vector (Amer-
sham Pharmacia Biotech, Piscataway, NJ). For cellular expression and
interaction analyses in mammalian cells, eIF3g was cloned into the
pEBG vector (New England BioLabs, Beverly, MA) and the pEG-
FPC2 vector (Clontech). All cDNA constructs were veriﬁed by auto-
matic DNA sequencing and their protein expression was conﬁrmed
by Western blotting.2.4. Yeast two-hybrid screening and b-galactosidase assay
The LexA-based yeast two-hybrid system was used to screen
for AIF-interacting proteins. The yeast used in this study was
Saccharomyces cerevisiae strain EGY48 (MATa, his3, trp1, ura3,
LEU2::LexAop(x6)/pSH18-34). Cloned pLexA-AIFmat plasmid was
transformed into the yeast via lithium acetate-mediated transforma-
tion, and the clones growing in selection media were cultured. After
examination of Lex-AIFmat’s expression and self-transcription activ-
ity, the HeLa cDNA library DNA (10 lg) was transformed into the
LexA-AIFmat-yeasts, and positive clones were isolated using a
colony-lift ﬁlter assay according to the Clontech Matchmaker manual
(Clontech). Library plasmids from positive clones were extracted and
the plasmids were identiﬁed by DNA sequencing and the NCBI Blast
Program. To conﬁrm the interaction of AIF and eIF3g, yeasts were
co-transformed with the diﬀerent AIF and eIF3g wt or deletion
mutants and a b-galactosidase assay was performed. In brief, yeasts
containing diﬀerent sets of plasmids were cultured until mid-log phase
was achieved. Yeasts were lysed with liquid nitrogen and the ﬂuoro-
metric reaction was initiated by adding the substrate ONPG in Z buﬀer
(60 mM Na2HPO4 Æ 12H2O, 40 mM NaH2PO4 Æ 2H2O, 10 mM KCl,
1 mM MgSO4 Æ 7H2O, pH 7.0) containing 2-mercaptoethanol. b-
Galactosidase activity was calculated according to the Clontech
Matchmaker manual.2.5. GST pull-down assay
GST, GST-AIF, or GST-eIF3g plasmids were transformed into
E. coli BL21 (DE3) and the protein expression was induced by the
addition of IPTG up to a concentration of 1 mM at 37 C for 4 h.
The GST or GST-fusion proteins were extracted using a lysis buﬀer
(20 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton
X-100, 1 mM PMSF). The lysates were immobilized onto glutathi-
one-Sepharose 4B resin (Amersham) at 4 C for 4 h. In order to
generate 35S-Met-labeled proteins using the TNT coupled transcrip-
tion-translation system (Promega, Madison, WI), pcDNA3 constructs
and 35S-methionine (Perkin-Elmer Life Sciences, Boston, MA) were
added to the TNT reticulocyte lysates, and the lysates were incubated
at 30 C for 90 min. For the GST pull-down assay, the immobilized
GST or GST-fusion proteins were incubated with mammalian cell ly-
sates (1 mg) or in vitro 35S-labeled proteins at 4 C for 4 h. After pull-
down, proteins remaining on the Sepharose beads were resuspended
with SDS sample buﬀer, resolved using SDS–PAGE, and analyzed
by Western blotting or autoradiography.2.6. In vitro translation assay
GST or GST-fusion proteins immobilized onto Sepharose resin were
eluted with glutathione elution buﬀer (50 mM Tris–HCl, pH 9.0,
20 mM glutathione) according to manufacturer’s instructions. The
eluted GST or GST-fusion proteins were then incubated with TNT
reticulocyte lysate at 4 C for 4 h. Both T7 luciferase DNA and
10 lCi of 35S-Met were added to the recombinant protein–reticulocyte
mixtures, and then reincubated for at 30 C for 90 min. Alternatively,
35S-Met, pcDNA3-AIFmat, and/or pcDNA3-eIF3g were added to the
TNT reticulocyte lysate and incubated at 30 C for 1 h. Then,
pcDNA3-GFP plasmid was added and the mixtures were reincubated
for 1 h. After the reaction was stopped by SDS sample buﬀer, the new-
ly synthesized 35S-Met-labeled proteins were analyzed by SDS–PAGE
and autoradiography.
J.-T. Kim et al. / FEBS Letters 580 (2006) 6375–6383 63772.7. Transfection, immunoprecipitation, and Western blotting
Cells were distributed into 6-well or 100 mm plates and transfected
with various plasmids using Lipofectamine transfection reagent (Invit-
rogen). After 24–48 h, the cells were washed with PBS (137 mM NaCl,
2.7 mM KCl, 4.3 mM Na2HPO4 Æ 7H2O, 1.4 mM KH2PO4, pH 7.4),
lysed by RIPA lysis buﬀer (1% NP-40, 1% sodium deoxycholate,
0.1% SDS, 150 mM NaCl, 10 mM Tris–HCl, pH 7.6, 1 mM EDTA,
50 mM sodium ﬂuoride, 1 mM PMSF, and protease cocktail), and
then incubated on ice for 30 min. After the removal of cell debris via
centrifugation at 12000 rpm for 10 min, protein content was deter-
mined using the Bio-Rad protein assay system (Bio-Rad Laboratories,
Hercules, CA). To degrade nucleic acids in cell lysates, lysates were
treated together with DNase and RNase A at 37 C for 1 h. For immu-
noprecipitation, anti-AIF or anti-GST antibodies (2 lg) were added
into the cell lysates (1 mg) at 4 C for 4 h, and then protein-A/G aga-
rose was added and the lysates were reincubated for 2 h. After centri-
fugation, precipitated immune complexes were resuspended in SDS
sample buﬀer. The quantiﬁed lysates or immune complexes were sub-
jected to SDS–PAGE, and subsequently transferred onto Hybond
PVDF membranes (Amersham). The membranes were blocked with
5% non-fat dry milk in PBS, and then incubated with the appropriate
primary and HRP-conjugated secondary antibodies at room tempera-
ture for 2 h. Following another extensive washing, protein bands were
visualized using an enhanced chemiluminescence (ECL) Western blot-
ting detection kit (Amersham).2.8. Reverse-transcriptase (RT)-PCR analysis
Total RNA was extracted from the transfected cells by the acid
guanidinium thiocyanate-based extraction method and the RNAs were
dissolved in 0.1% diethylpyrocarbonate-treated water. cDNA was syn-
thesized from RNA using a ProSTAR RT-PCR kit (Stratagene, La
Jolla, CA) according to the manufacturer’s instructions. PCR-ampli-
ﬁed cDNAs were separated on a 1.2% agarose gel and stained with
ethidium bromide.2.9. Detection of caspase activation
To detect active caspase in apoptotic cells, we used a Carboxyﬂuores-
cein FLICA Apoptosis Detection Kit (Immunochemistry Technolo-
gies, Bloomington, MN) according to manufacturer’s instructions. In
brief, MCF-7 cells growing on coverslips were transfected with
pcDNA3-AIFmat and then treated with FAM-DEVD-fmk, an active
caspase-3/7 substrate, for 1 h in a CO2 incubator. After washing with
DMEM, the cells were stained with Hoechst dye and anti-AIF anti-
body. To measure caspase activity directly, MCF-7 cells were transfec-
ted with pcDNA3 constructs and treated with Z-DEVD-fmk (0.5 lM,
Calbiochem) or cisplatin (10 lg, Sigma) for 1 day. Cells were harvested,
lysed, and incubated with Caspase-Glo 3/7 Reagent (Promega) for
10 min at room temperature, and the luminescence was then assessed
using a plate-reading luminometer (Turner Designs, Sunnyvale, CA).
2.10. Immunoﬂuorescence confocal microscopy
Cells grown on coverslips were transfected with pEGFP or pEGFP-
eIF3g, and the cells were treated with cisplatin for 1 day. The cells were
washed with PBS, ﬁxed in 4% paraformaldehyde for 20 min, and per-
meabilized with 0.3% Triton X-100/PBS for 10 min. After washing,
cells were blocked in 1% BSA/PBS for 30 min at room temperature,
washed, and incubated with anti-AIF antibody for 1 h, followed by
incubation with TRITC-conjugated anti-goat antibody. Cells were
then treated with DAPI (Calbiochem), and washed with PBS contain-
ing 0.1% Triton X-100. Cell-containing coverslips were mounted onto
glass slides with Vectashield mounting medium (Vector Laboratories,
Burlingame, CA), and visualized using a Zeiss confocal microscope
LSM510META (Carl Zeiss, Jena, Germany) at 40· magniﬁcation.
The confocal images were captured by the Zeiss LSM Image Browser
program.3. Results
3.1. AIFmat interacts with eIF3g in yeast two-hybrid system
In order to gain an understanding of the mechanism under-
lying the function of AIF, we initially searched for AIF bind-ing proteins in a human HeLa cDNA library, using the yeast
two-hybrid screening method. AIFmat cDNA, the mature
form of AIF which translocates from mitochondria to the nu-
cleus during apoptosis, was cloned into the pLexA vector, and
the expression of LexA-AIFmat protein was examined by
Western blotting. Before library screening, we also examined
the self-transcription activity of AIFmat and found that AIF-
mat expression alone did not activate the reporter gene, b-
galactosidase. According to the results of DNA sequencing
and NCBI database searches from the AIFmat-interacting po-
sitive clones, the nucleotide sequences of 4 of the 12 cDNA
clones isolated actually encoded for the eukaryotic translation
initiation factor 3 subunit p44 (eIF3g) (data not shown).3.2. AIFmat interacts with eIF3g in vitro
To determine whether or not eIF3g interacts directly with
mature AIF, we performed an in vitro binding study using re-
combinant GST-fusion proteins and in vitro 35S-Met-labeled
proteins. Recombinant GST-AIFmat and GST-eIF3g fusion
proteins were generated in E. coli, and their protein expres-
sions were veriﬁed via Western blot analysis. In order to ana-
lyze protein interactions occurring between AIFmat and
eIF3g, immobilized GST fusion proteins were incubated with
35S-Met-labeled proteins. After the GST pull-down, pelleted
proteins were subjected to SDS–PAGE, followed by autoradi-
ography (Fig. 1A and B). AIF and AIFmat proteins interacted
strongly with eIF3g, but not with eIF3i, eIF3j, or GST alone.
The eIF3i and eIF3j subunits have been demonstrated to form
the eIF3 complex with eIF3g. The S. cerevisiae eIF3g (TIF35)
has been previously demonstrated to interact speciﬁcally with
eIF3b (PRT1) and eIF3i (TIF34) in the yeast two-hybrid sys-
tem [13–15]. Alternatively, when mammalian cell lysates from
HeLa, Jurkat, or HEK293 cells were incubated with GST-
eIF3g protein, AIF protein was detected by Western blot using
anti-AIF antibody, indicating that this endogenous AIF pro-
tein interacted strongly with the eIF3g protein (Fig. 1C).
Along with the results from the yeast two-hybrid assay, these
results bolster the assertion that eIF3g interacts speciﬁcally
with AIF in vitro.3.3. AIFmat interacts with eIF3g near the nucleus
The interaction of AIF and eIF3g was conﬁrmed by immu-
noprecipitation assay in HEK293 cells. To test whether cellular
AIF associates with eIF3g in vivo, cells were transfected with
AIFmat and eIF3g fused with GST. When the lysates from
these transfectants were examined, endogenous AIF, exoge-
nous AIFmat, and GST-eIF3g protein expression was detected
by Western blotting. Cell lysates were initially immunoprecip-
itated with anti-GST antibody and co-precipitated proteins
were then detected using anti-AIF antibody (Fig. 2A). AIF
and AIFmat were detected in GST-eIF3g lysate, but not in
GST lysate. Also, when the lysates were immunoprecipitated
with anti-AIF antibody, co-precipitated proteins were detected
as fusion proteins by Western blot, using anti-GST antibody.
Alternatively, in order to obtain direct evidence for in vivo
interaction, immunoprecipitation using anti-AIF antibody
was performed in the AIFmat-transfected lysates. In this
experiment, because eIF3g contains an RNA recognition motif
(RRM) and AIF binds to DNA, cell lysates were treated with
nucleases to exclude the nucleic acids (Fig. 2B). The direct
interaction of AIF with eIF3g was signiﬁcantly detected even
Fig. 1. AIF interacts with eIF3g in vitro. Puriﬁed recombinant GST or
GST-fusion proteins that were generated from E. coli were immobi-
lized onto glutathione resin, and 35S-Met-labeled proteins were
generated using a TNT coupled transcription–translation reticulocyte
lysate system. These resin-bound GST or GST-fusion proteins were
incubated with 35S-proteins or mammalian cell lysates, and a GST
pull-down assay was performed. (A) GST or GST-eIF3g protein was
incubated with 35S-labeled AIF. After GST pull-down, protein pellets
were resuspended in SDS sample buﬀer and subjected to SDS–PAGE
followed by autoradiography. (B) GST-AIF or GST-AIFmat protein
was incubated with 35S-eIF3g, -eIF3i, or -eIF3j protein, and GST
pull-down was performed. 35S-eIF3g protein was co-precipitated with
GST-AIF and GST-AIFmat, but 35S-eIF3i and -eIF3j were not co-
precipitated with GST-AIFmat. (C) GST-eIF3g protein was incubated
with mammalian cell lysates, instead of 35S-labeled proteins. After the
GST pull-down, the pellets were subjected to SDS–PAGE followed by
Western blotting for AIF. Input was 10% of incubation lysates.
Fig. 2. AIF directly interacts with eIF3g near nucleus. (A) HEK293
cells were transiently transfected with pcDNA3-AIFmat and pEBG
(GST)-eIF3g, and the cell lysates were prepared and immunoprecip-
itated with anti-GST or anti-AIF antibody. After immunoprecipita-
tion, the immune complexes were resuspended in SDS sample buﬀer,
subjected to SDS–PAGE, and analyzed by Western blotting. AIF and
AIFmat were pulled down with GST-eIF3g by using an anti-GST
antibody, and GST-eIF3g was pulled down with AIFs by using an
anti-AIF antibody. (B) AIFmat-transfected cell lysates were incubated
with or without nucleases to degrade their nucleic acids, and these
lysates were immunoprecipitated with anti-AIF antibody. eIF3g was
detected in the AIF-immunoprecipitated pellets regardless of pretreat-
ment with nuclease, but not detected in the pellet immunoprecipitated
with IgG control antibody. HC, heavy chain of immunoglobulin. (C)
Cells were transfected with GFP or GFP-eIF3g and were treated with
cisplatin for 1 day. For immunoﬂuorescence analysis, the cells were
ﬁxed and stained with anti-AIF antibody (red) and DAPI (nuclei, blue)
as described in Section 2. After examination of protein expression
using Western blotting, cellular localization of AIF and eIF3g were
analyzed using a confocal microscope. Arrows indicate the co-
localization of AIF and eIF3g. Bar, 50 lm.
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mat and eIF3g was viewed on a confocal microscope. To do
this, HEK293 cells were transfected with GFP or GFP-eIF3g
plasmid and the cells were treated with cisplatin to induce
apoptosis. As shown in Fig. 2C, GFP proteins appeared to
be equally distributed within the cells, but GFP-eIF3g proteins
were found to be mainly distributed throughout the cytosol,
while being only weakly distributed in the nucleus. In the case
of AIF, nuclear translocation was partially observed with the
induction of apoptosis using 5 lg/ml cisplatin. Importantly,
under the same conditions, the region of mature AIF and
eIF3g co-localization was identiﬁed near the nuclear mem-
brane, presumably in the endoplasmic reticulum (Fig. 2C, ar-
rows). Consistent with these ﬁndings, the co-localization of
GFP-AIF155–613 with endogenous eIF3g was also detected
by anti-eIF3g antibody (data not shown). This co-localization
indicates that mature AIF might associate with eIF3g near the
nucleus in apoptotic induction. Therefore, our results indicate
that mature AIF proteins do indeed interact with eIF3g
in vivo.3.4. The AIF C-terminus and eIF3g N-terminus are important
for their protein binding
In order to construct a map of the region of AIF which binds
to eIF3g, we generated various protein fragments of AIF or
eIF3g, forming LexA-fusion or B42-fusion proteins (Fig. 3A).
These deletion mutant constructs of AIF and eIF3g were trans-
formed into yeast EGY48, and their protein interaction was
determined by measurement of the expression levels of the lacZ
reporter gene. As shown in Fig. 3B, AIF and AIFmat exhibited
strong binding to eIF3g, whereas AIF-N, -M1, -M2, and -M3
(deletion mutants of the C-terminal residues) revealed no inter-
action with eIF3g. However, the C-terminal fragments of AIF
that contained the nuclear localization sequence 2 (NLS2),
encompassing amino acids 373–613 (AIF-C2) and 440-613
(AIF-C1), both interacted signiﬁcantly with eIF3g. On the
Fig. 3. Determination of binding site between AIF and eIF3g. (A)
Schematic diagrams of AIF and eIF3g deletion mutants. AIF contains
a MLS at the N-terminus and two NLS, and eIF3g contains a RRM at
C-terminus. (B) b-Galactosidase reporter assay for the protein
interaction between AIF and eIF3g. Various combinations of pLexA-
and pB42-constructs plasmids were co-transformed into EGY48 yeast,
and colonies growing in selection media were cultured. Exponentially-
growing yeast cells were lysed and b-galactosidase activity was
determined as described in Section 2. b-Galactosidase activity indicates
that the LexA-fusion protein interacts with the B42-fusion protein.
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units such as eIF3i and eIF3j (This was veriﬁed in Fig. 1B),
whereas AIFmat interacted strongly with another AIFmat pro-
tein. When we expressed the deletion mutants of eIF3g, AIF-
mat interacted only with eIF3gDR (D230–320), which does
not harbor the RRM, and not with eIF3g-C1 (230–320),
eIF3g-C2 (114–320), eIF3gDN (D1–74), or the pB42AD vector
alone. The interaction of eIF3g with the eIF3i subunit, but not
the eIF3j subunit, was conﬁrmed for positive interactions, as re-
ported by others [15–17]. These results indicate that the region
directly interacting with the C-terminal region of AIF is the N-
terminal region of eIF3g.
3.5. AIF inhibits de novo protein synthesis by binding to eIF3g
As the eIF3 complex is important for de novo protein syn-
thesis, and eIF3g is required for eIF3’s function, we therefore
examined whether the interaction of AIFmat with eIF3g plays
a role in protein biosynthesis. When GST-AIFmat protein was
incubated with TNT reticulocyte lysate, the synthesis of 35S-
Met-labeled luciferase protein by luciferase DNA was inhib-
ited in a dose-dependent manner, but GST protein did not
aﬀect the synthesis (Fig. 4A). In the TNT reticulocyte lysates,
AIF protein was not detected by Western blotting (data not
shown), excluding the possible contribution of AIF fromTNT reticulocyte lysate. Furthermore, upon the addition of
increasing amounts of GST-eIF3g protein to the reaction mix-
tures containing GST-AIFmat, the repressed luciferase synthe-
sis was signiﬁcantly recovered (Fig. 4B). The recovery of
translation was almost complete after the addition of GST-
eIF3g in an equal proportion to GST-AIFmat protein, and
this speciﬁcity was also veriﬁed by GST as a negative control.
Alternatively, when AIFmat DNA was used instead of recom-
binant protein, 35S-Met-GFP synthesis by GFP DNA added
later was blocked by the synthesis of AIFmat by the previ-
ously-add DNA, resulting in a time-dependent decrease in
GFP protein expression (Fig. 4C). Also, as shown in
Fig. 4D, when AIFmat and eIF3g DNAs were co-expressed
in TNT reticulocyte lysate (lane 1), 35S-Met-GFP synthesis
by GFP DNA was similar to that in the presence of eIF3g
alone (lane 2) or in mock control (lane 4), whereas it was sig-
niﬁcantly inhibited in AIFmat-expressing reticulocyte lysate
(lane 3). Taken together, these results strongly suggest that
mature AIF associates with its interacting protein, eIF3g,
thereby blocking de novo protein synthesis.
To conﬁrm AIFmat’s function in cellular protein synthesis,
HEK293 cells were transfected with AIF mutants and GFP
plasmids, and the expression level of GFP protein was ana-
lyzed by Western blotting (Fig. 4E and F). When AIFmat or
AIF-C1, both of which are able to bind eIF3g, was overexpres-
sed, GFP protein expression decreased in the cell lysates in an
AIF dose-dependent manner. However, the inhibition of pro-
tein synthesis was not found when AIF-M2, which does not
bind to eIF3g, was overexpressed. It is noteworthy that the
attenuation of GFP expression occurred at the level of protein
synthesis, not at the mRNA level. Similar to the in vitro results
with eIF3g, eIF3g expression in HEK293 cells recovered GFP
expression repressed by AIFmat expression (Fig. 4F). How-
ever, AIF, an immature form of AIF that is localized to the
mitochondrial intermembrane space, did not aﬀect GFP
expression level (data not shown). These results indicate that
mature AIF from mitochondria speciﬁcally interacts with
eIF3g subunit of eIF3 complex, thereby blocking protein syn-
thesis.3.6. AIFmat is involved in caspase-7 activation
As it has been established that caspase activation modiﬁes
substrates such as eIF2-a, eIF3j, and eIF4B, constituents of
the eIF complex, and plays an important role in protein syn-
thesis, we attempted to determine whether the AIFmat-medi-
ated inhibition of translation is related to caspase activity.
For this study, cells were transfected with GFP and AIFmat,
followed by the addition of Z-DEVD-fmk, a caspase-3/7 inhib-
itor. Finally, cells were treated with cisplatin as an apoptosis-
inducing agent. As shown in Fig. 5A, cisplatin treatment
induced relatively weak caspase activation, resulting in the
inhibition of GFP expression (lanes 2 and 3). Interestingly,
the cisplatin-induced translation inhibition and caspase-3 acti-
vation were ampliﬁed by the exogenous expression of AIFmat
(lanes 5 and 6). Decreased GFP expression, by either cisplatin
alone or cisplatin in combination with exogenous AIFmat, was
recovered via treatment with Z-DEVD-fmk (lanes 4 and 7).
More importantly, the inhibition of translation by exogenous
AIFmat alone was also signiﬁcantly recovered by treatment
with Z-DEVD-fmk (lane 9), suggesting the involvement of
caspase activation in the AIFmat-mediated inhibition of
Fig. 4. AIFmat inhibits protein synthesis by binding to eIF3g. (A)
After puriﬁed recombinant GST or GST-AIFmat was incubated with
TNT coupled transcription–translation reticulocyte lysate for protein
interaction, 35S-Met and pcDNA3-luciferase DNA were added and
reincubated for protein synthesis. The reaction mixtures were then
analyzed by SDS–PAGE followed by autoradiography for 35S-lucif-
erase synthesis. GST-AIFmat addition dose-dependently inhibited the
Luc synthesis, but GST alone did not. (B) GST, GST-AIFmat, and/or
GST-eIF3g were incubated with the TNT reticulocyte lysate for their
protein interaction, then this mixtures were reincubated with luciferase
DNA and 35S-Met, and the 35S-Luc synthesis was analyzed by
autoradiography. GST-eIF3g rescued the Luc synthesis repressed by
GST-AIFmat. (C) Instead of recombinant protein addition into the
TNT lysate, pcDNA3-constructs were added to conﬁrm the translation
inhibition. pcDNA3-AIFmat and 35S-Met were added and incubated
at 30 C for the described time interval, and then GFP DNA was
added and reincubated for 1 h. Presynthesized AIFmat protein time-
dependently blocked the protein synthesis by GFP DNA added later.
(D) AIFmat and eIF3g DNAs were added together or alone with 35S-
Met into the TNT reticulocyte lysates, which were incubated to
generate protein for 1 h. Following this, GFP DNA was added and the
lysates reincubated for 1 h. As above, AIFmat blocked GFP protein
synthesis, but the addition of both AIFmat and eIF3g did not. (E)
HEK293 cells were transfected with GFP and AIF mutants, and
analyzed for their GFP expression by Western blotting and RT-PCR.
GFP expression was dose-dependently inhibited by AIF-C1, but not
by AIF-M2. Also, to compare the expression levels of RNA and
protein, RNA was extracted and RT-PCR was performed. Diﬀerential
expression of GFP protein depends on the AIF-C1 expression, while
RT-PCR for GFP mRNA shows that mRNA is expressed at the same
densities. a-tubulin or b-actin was used as a loading control. (F) After
transfection with GFP, AIFmat, and eIF3g, cell lysates were analyzed
by Western blotting for GFP expression. The decreased GFP
expression by AIFmat was dose-dependently recovered by eIF3g.
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served after treatment with cisplatin and AIFmat, and this
cleavage was inhibited in the presence of Z-DEVD-fmk (lanes
5–7). We observed that this cleavage of eIF3g upon apoptosis
induction occurred in several cell lines (data not shown). Addi-
tionally, when we determined the caspase activation in
HEK293 cells transfected with AIFmat or AIF mutants, the
reduction of procaspase-7, an indicator of caspase-7 activa-
tion, was clearly observed in cells transfected with AIFmat
and, to a lesser extent, in AIF-C1-cells (Fig. 5B). However, this
was not observed in cells transfected with AIF-M2, which
shows no binding activity to eIF3g. Caspase-3 activation, how-
ever, was not detected in any of the transfected cells. Using
MCF-7 cells, which are deﬁcient in caspase-3 expression, we
examined whether casapse-7 can be activated in AIFmat-over-
expressing cells. Cells were transfected with AIFmat and
labeled with FAM-DEVD-fmk, an active caspase-3/7 sub-
strate. As shown in Fig. 5C, caspase-7 activity was detected
in AIFmat-cells, but not in mock-transfected cells. Moreover,
direct detection of caspase activities using a proluminescent
substrate revealed that caspase-7 activity was induced in
MCF-7 cells transfected with AIFmat at more than 25% of
control level, and that it could be inhibited by treatment with
a caspase-3/7 inhibitor, Z-DEVD-fmk (Fig. 5D). Finally, the
increase of cisplatin-mediated cell death was observed after
AIFmat transfection, suggesting the involvement of caspase
activation by AIFmat expression. At the same time, co-locali-
zation of AIF and eIF3g in nucleus of apoptotic cell was also
conﬁrmed (data not shown).
Collectively, these data suggest that mature AIF released
from mitochondria during apoptosis interacts with eIF3g,
and thereby inhibits the eIF3 machinery and protein synthesis,
and activates casapse-7 to amplify apoptosis.4. Discussion
In our current study, we attempted to identify proteins that
interact with the mature AIF and isolated cDNA clones which
encode eIF3g protein. eIF3 is the largest of the mammalian
translation initiation factors, approximately 600 kDa, and ap-
pears to play a central role in the initiation of translation. It
was originally isolated from rabbit reticulocyte lysates, and
was found to contain at least 13 diﬀerent protein subunits
[20,22–24]. eIF3 has been shown to bind to 40S ribosomal sub-
units, stabilize initiator methionyl-tRNA binding to the 40S
subunits, and participate in mRNA binding via interaction
with eIF4G [25]. eIF3g, the p44 subunit of the eIF3 complex,
has been reported to strongly associate with eIF3a (p170) and
bind to rRNA through a RRM domain at the C-terminal re-
gion [21]. In S. cerevisiae yeast, it has been demonstrated that
eIF3g interacts with eIF4B, and that the central part of eIF3g
spanning amino-acids 66–173 is involved in binding to eIF4B
or eIF3i (p36), whereas the C-terminal part of eIF3g contrib-
utes to neither eIF4B nor eIF3i binding [26]. Moreover, it
was reported that eIF3g interacts directly with erythroid pro-
tein 4.1 (4.1R), and that the RRM of eIF3g is involved in this
binding [27]. Interestingly, the depletion of eIF3g from rabbit
reticulocyte lysate by the addition of anti-eIF3g antibody was
found to result in a reduction of the lysate’s ability to synthe-
size proteins eﬃciently. In our study, we have shown that, un-
Fig. 5. AIFmat activates caspase-7, not caspase-3. (A) After HEK293
cells were transfected with GFP and AIFmat for 1 day, cells were
treated with cisplatin and/or Z-DEVD-fmk (caspase-3/7 inhibitor) as
indicated. Cisplatin and AIFmat inhibited the GFP expression and this
expression was recovered by caspase inhibitor. AIFmat more strongly
blocked the GFP protein synthesis with cisplatin treatment (lanes 5
and 6), and the decreased GFP expression was signiﬁcantly recovered
by Z-DEVD-fmk (lane 7). Under this condition, eIF3g was signiﬁ-
cantly cleaved concomitantly with caspase activation. Also, when
AIFmat was expressed without cisplatin treatment, the decreased GFP
expression was recovered by Z-DEVD-fmk, indicating that AIFmat is
related to caspase activity. (B) Cells were transfected with AIF mutants
and analyzed by Western blotting for caspases. Caspase-7 was
activated by AIFmat and AIF-C1, whereas caspase-3 was not
activated by AIF mutants. (C) MCF-7 cells on coverslips were
transfected with pcDNA3 or pcDNA3-AIFmat, and the cells were
incubated with FAM-DEVD-fmk (caspase-3/7 substrate). Then, the
cells were ﬁxed and stained with Hoechst dye (blue) and anti-AIF
antibody (red). AIF, caspase-7, and nuclear stain were detected using
confocal microscopy. Bright green spots in AIFmat panels indicate
that casapse-7 is activated. bar, 50 lm. (D) MCF-7 cells were
transfected with AIF or AIFmat and treated with Z-DEVD-fmk.
Cells were harvested, lysed and incubated with Caspase-Glo 3/7
Reagent (a caspase-3/7 substrate). The luminescence of each sample in
duplicate was measured with a plate-reading luminometer. Results are
means ± S.E.M. of three independent experiments. *, P < 0.05, AIF
versus AIFDN.
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ence of the RRM for association with AIF. We could clearly
demonstrate that the AIF C-terminus interacts with the eIF3g
N-terminus, which lacks the RRM motif, to inhibit protein
synthesis in vivo and in vitro. Furthermore, the addition of
increasing amounts of mature AIF to the lysates resulted ina remarkable reduction of protein translation activity. This de-
creased activity was obviously attributable to interaction with
eIF3g, as the inhibition of translation was eﬃciently blocked
by an additional amount of eIF3g, possibly due to competitive
interaction. Although both AIF precursor and mature AIF
interact with eIF3g in our binding experiments, AIF precursor
containing MLS is known to be localized in the mitochondrial
intermembrane space. Upon apoptosis induction, N-terminal
MLS is removed by cleavage and mature AIF is released from
mitochondria. In fact, mature AIF, but not precursor AIF,
inhibits the protein translation signiﬁcantly (data not shown),
and it also activates caspase-7 better than precursor AIF as
shown in Fig. 5D. Recently, another subunit of the eIF3 com-
plex, eIF3f (p47), was observed to interact with cyclin-depen-
dent kinase 11 (CDK11), and this interaction was found to
be strengthened by the stimulation of apoptosis [28]. They
showed that the caspase-processed C-terminal kinase domain
of CDK11 resulted in the in vivo inhibition of the synthesis
of a transfected luciferase reporter protein via interaction with
eIF3f. Similarly, our data has revealed that AIF is deﬁnitely
able to interact with eIF3g in the cytoplasm, especially in the
perinuclear region (probably the ER) upon apoptotic stimula-
tion, and that eIF3g can be one of the apoptotic target proteins
that lose its functions during apoptotic process.
Whether protein synthesis is absolutely required for apopto-
sis to occur remains a matter of debate, and may vary based on
stresses and cell types. In certain situations, de novo protein
synthesis appears necessary for the induction of apoptosis.
For example, p53-induced apoptosis has been demonstrated
to require new protein synthesis for the full program to be
completed [29]. It has also been reported that p53 results in
the downregulation of overall translation at the level of poly-
peptide chain initiation, and p53 activation results in the cas-
pase-independent downregulation of translation, along with
the cleavage of eIF4GI and eIF4B, both of which are critical
for protein synthesis [30,31]. Conversely, other reports have
shown that apoptotic induction leads to the rapid caspase-
dependent cleavage of initiation factors eIF4GI, eIF4GII,
eIF4B, eIF2alpha, and the p35 subunit of eIF3 (eIF3j) [32–
34]. A recent report has shown that protein synthesis is rapidly
shut down in apoptosis, but not in necrosis, whereas transla-
tion initiation factors such as eIF4G and eIF2-a remain intact
in necrosis, but not in apoptosis [35]. Interestingly, we found
that the cleavage of eIF3g occurs in cells undergoing apoptosis
after treatment with cisplatin and AIFmat. In several apopto-
tic cells, the polyclonal antibody against eIF3g has detected
both the complete eIF3g (p44, 44 kDa) and its processed large
fragments (30 kDa). Currently, we are examining eIF3g’s cas-
pase cleavage site, and the cellular localization of the cleaved
eIF3g fragment. Importantly, cell death induced by AIF might
be associated with a yet undeﬁned function of eIF3g. It has re-
cently been reported that the subcellular localization of eIF3g
can change in apoptosis by anti-Fas stimulation and the
knock-down of this protein may alter the apoptotic process
[36]. In this study, we demonstrated that the cleavage of eIF3g
occurs in cells undergoing apoptosis after the interaction of
AIF with eIF3g followed by caspase activation. This observa-
tion strongly suggests that the translation inhibition of AIF is
primarily mediated by interaction with eIF3g at an early time
point, and that this inhibition of protein synthesis can be
potentiated through the cleavage of eIF3g by caspase activa-
tion. Although the mechanism underlying caspase-7 activation
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mat-mediated inhibition of protein synthesis can be recovered
by caspase-7 inhibitor in HEK293 and MCF-7 cells. In MCF-7
cells, it has been shown that AIFmat transfection also induces
caspase-7 activation.
The idea that AIF can induce caspase-independent death is
based on several key pieces of evidence. Some reports, how-
ever, suggest that crosstalk between AIF and caspases is possi-
ble. At least in some cases, AIF has been reported as an
essential apoptotic factor released from mitochondria in the
Cyt-c-dependent caspase activation cascade [37,38]. Recently,
it has also been demonstrated that AIF can interact with
HSP70, an inhibitor of Apaf-1-dependent caspase activation,
indicating that another level of crosstalk may exist between
AIF and caspases [17,39,40]. HSP70 is, therefore, the ﬁrst
cytoplasmic protein reported to interact with AIF, and its
anti-apoptotic action may be attributed to AIF binding, which
results in the cytosolic retention of AIF. HSP70, therefore,
appears to be one of many candidates exhibiting anti-apopto-
tic functions. In another report, it has been suggested that AIF
is capable of interacting and cooperating with cyclophilin A
(CypA) to induce apoptosis-associated chromatinolysis [19].
It has been demonstrated that AIF translocates to the nucleus,
where its interaction with CypA causes DNA degradation.
Although this observation constitutes biochemical evidence
that AIF induces chromatin condensation and DNA fragmen-
tation, the AIF/CypA interaction cannot be the only factor
determining the AIF-mediated regulation of cell death. In
our study, we provide several lines of evidence supporting a
role for AIF in protein translation and synthesis. Although a
number of studies currently focus on the functional role of
AIF in the nucleus, such as the induction of nuclease activity
for DNA fragmentation, our observations reveal a new aspect
of AIF-mediated apoptosis in the cytoplasm, prior to its trans-
location into the nucleus.
Taken together, this study demonstrates that AIF liberated
from the mitochondria interacts with eIF3g, a subunit of the
eIF3 complex, thereby inhibiting de novo protein synthesis,
and ﬁnally activating caspase-7 for apoptosis ampliﬁcation.
Our data suggest that eIF3g is one of the target proteins
for activated AIF, and our results also indicate that the
modulation of translational activity constitutes a further
mechanism by which the apoptotic eﬀect of AIF may be
mediated. Therefore, a detailed analysis of AIF’s interaction
with eIF might result in a clearer understanding of the func-
tions of AIF, providing new insight into the mechanisms
underlying apoptotic signaling and translational machinery
collapse.
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